INS and diabetes mellitus: Overcoming clinical inertia by early initiation of a combination therapy or insulin therapy could help in achieving glycaemic targets faster in people who are poorly controlled on monotherapy and thus alleviate the burden of diabetes‐related vascular complications.21, 22